CANCER – THYROID

 

Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth (full – 2001)  http://www.fasebj.org/cgi/reprint/15/14/2745?ijkey=1b6e92836655dd275d36c82a7957423ec2106c6a

 

Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis1 (full – 2003)          http://www.fasebj.org/cgi/reprint/17/12/1771

 

 

A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. (full – 2006)                                                  http://www.fasebj.org/content/early/2004/10/02/fj.04-1754fje.long

 

Endocannabinoids in endocrine and related tumours                   (full – 2008)

http://erc.endocrinology-journals.org/cgi/reprint/15/2/391.pdf

 

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.                                                            (full – 2008)  http://www.nature.com/cgt/journal/v15/n2/full/7701101a.html

 

A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis                                                            (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19189054/abstract/A_metabolically_stable_analog  ue_of_anandamide_Met_F_AEA_inhibits_human_thyroid_carcinoma_cell_lines_by_activation_of_apopto sis_

 

Share a link for